VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $765,000 | +16.4% | 31,150 | -4.5% | 0.30% | +24.2% |
| Q2 2016 | $657,000 | -19.1% | 32,615 | +5.6% | 0.24% | -16.7% |
| Q1 2016 | $812,000 | -69.4% | 30,890 | +18.2% | 0.29% | -65.3% |
| Q4 2015 | $2,656,000 | -6.2% | 26,130 | +64.7% | 0.83% | -12.3% |
| Q3 2015 | $2,831,000 | -23.1% | 15,870 | -4.2% | 0.95% | -19.9% |
| Q2 2015 | $3,681,000 | +0.5% | 16,570 | -10.1% | 1.18% | +7.5% |
| Q1 2015 | $3,661,000 | +22.1% | 18,430 | -12.0% | 1.10% | +24.2% |
| Q4 2014 | $2,999,000 | +16.7% | 20,955 | +7.0% | 0.88% | +16.4% |
| Q3 2014 | $2,569,000 | +6.2% | 19,580 | +2.1% | 0.76% | -4.8% |
| Q2 2014 | $2,419,000 | -2.1% | 19,180 | +2.4% | 0.80% | -8.5% |
| Q1 2014 | $2,470,000 | +22.8% | 18,735 | +9.4% | 0.87% | +25.1% |
| Q4 2013 | $2,011,000 | – | 17,125 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |